This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.
MK-677 (ibutamoren) is an orally active growth-hormone secretagogue. Note: it's a non-peptide small molecule, not a peptide, but it's grouped here because it targets the same ghrelin/GH pathway. It is not approved in any country.
How it works
It mimics ghrelin at the growth-hormone-secretagogue receptor, prompting GH release and raising IGF-1 — while, unusually for this class, being active as an oral tablet with a ~24-hour half-life.
The evidence
Studies document large increases in IGF-1 and GH, increased lean mass, deeper slow-wave sleep, and a strong appetite increase. But it is not approved for any use, and a clinical trial was terminated over a cardiac safety signal.
Safety
The notable concerns are insulin resistance and higher blood glucose (from sustained IGF-1 elevation), fluid retention, increased appetite, and the cardiac safety signal above. Anything that chronically raises GH/IGF-1 warrants caution and monitoring.
FAQ
QIs MK-677 a peptide?
No — it's a small-molecule ghrelin mimetic. It's grouped with peptides because it targets the same GH pathway, but chemically it's different.
QWhy is insulin resistance a concern?
Sustained IGF-1 elevation can reduce insulin sensitivity over time, potentially raising glucose — a reason bloodwork and clinical oversight matter.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
- Ibutamoren (Wikipedia)
- MK-677 effect on somatic growth (PMC)
- Ibutamoren clinical evidence guide (Body Nutrition)
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Questions & comments
No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.